Health and Healthcare
Diplomat Turns Bunt Pricing Into Homerun for IPO Buyers
Published:
Last Updated:
Source: Thinkstock
Diplomat is the largest independent and the overall fourth-largest specialty pharmacy company in the United States. The company offers customized care management programs for patients with complex chronic diseases. The other specialty pharmacy businesses are divisions of Express Scripts Holding Co. (NASDAQ: ESRX), CVS Health Corp. (NYSE: CVS), and Walgreen Co. (NYSE: WAG).
The company sold 10 million shares in the IPO, raising $130 million at a market cap of about $750 million. Selling shareholders sold the remaining shares.
Underwriters, including lead managers Credit Suisse Securities and Morgan Stanley, have a 30-day option on an additional 1 million shares from both the company and the selling shareholders.
The stock traded up nearly 26% at $16.35 about half an hour before noon on Friday. The range for the day was $15.04 to $17.75. Nearly 6 million shares had traded thus far.
ALSO READ: The 10 Safest High-Yield Dividends
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
